Executive Appointment, Second Show Schedule, Technical Updates, Movie Debut, and Compliance to Rules - Analyst Notes on Cinemark, MadisonSquareGarden, King, IMAX and Diamond

NEW YORK, June 26, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Cinemark Holdings Inc. (NYSE: CNK), The Madison Square Garden Company (NASDAQ: MSG), King Digital Entertainment plc (NYSE: KING), IMAX Corporation (NYSE: IMAX) and Diamond Resorts International, Inc. (NYSE: DRII). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4147-100free.

--
Cinemark Holdings Inc. Analyst Notes
On June 23, 2014, Cinemark Holdings Inc. (Cinemark) announced the appointment of Sean Gamble as the Company's Executive Vice President and CFO, effective August 25, 2014. Prior to joining Cinemark, Mr. Gable served as Executive Vice President and CFO at NBCUniversal, where he was responsible for Universal Picture's global financial operations. Cinemark's CEO, Tim Warner commented, "We are thrilled to welcome Sean to our Cinemark family. His diverse business background will be an outstanding addition to our Cinemark team. In his new role, Sean will be responsible for overseeing the company's financial performance, managing the company's global financial departments and developing key partnerships within the financial community that will help Cinemark continue to grow and prosper." The full analyst notes on Cinemark are available to download free of charge at:

http://www.analystsreview.com/Jun-26-2014/CNK/report.pdf

--
The Madison Square Garden Company Analyst Notes
On June 20, 2014, The Madison Square Garden Company's entertainment arm MSG Entertainment announced the second show of the British rock band Bastille, which is an addition to the previously announced show on October 9, 2014, in response to overwhelming demand. The Company informed that the band will perform at Radio City Music Hall on Friday, October 10, 2014 for the second show. Tickets for the newly added show go on sale on June 20, 2014 at 1:00PM EST. The full analyst notes on Madison Square Garden are available to download free of charge at:

http://www.analystsreview.com/Jun-26-2014/MSG/report.pdf

--
King Digital Entertainment plc Analyst Notes
On June 23, 2014, shares of King Digital Entertainment plc (King) closed trading at $17.05, reflecting a 0.64% decline. Over the past five trading days, King's shares gained 0.59% compared to the Dow Jones Industrial Average which gained 0.93% during the same period. The full analyst notes on King are available to download free of charge at:

http://www.analystsreview.com/Jun-26-2014/KING/report.pdf

--
IMAX Corporation Analyst Notes
On June 18, 2014, IMAX Corporation (IMAX) together with Warner Bros. Pictures announced that the IMAX®3D documentary adventure Island of Lemurs: Madagascar will make its debut in IMAX 3D theaters across North America, starting August 22, 2014. The 3D documentary, which is directed by David Douglas, focuses on Dr. Patricia C. Wright's wildlife conservation work, for which she recently received the prestigious Indianapolis Prize. Greg Foster, Senior Executive Vice President, IMAX and CEO of IMAX Entertainment, said, "Island of Lemurs: Madagascar brings IMAX 3D cameras to perhaps the most compelling region for wildlife on the planet, capturing this environment in the clearest, most vibrant way possible. As proven with IMAX documentaries such as Born to Be Wild 3D, Morgan Freeman is the perfect guide to lead moviegoers through this one-of-a-kind experience." The full analyst notes on IMAX are available to download free of charge at:

http://www.analystsreview.com/Jun-26-2014/IMAX/report.pdf

--
Diamond Resorts International, Inc. Analyst Notes
On June 13, 2014, Diamond Resorts International, Inc. (Diamond) announced that the Company's Chairman of the Board, Stephen J. Cloobeck and Vice Chairman of the Board, Lowell D. Kraff has each established a pre-arranged stock sale plan in accordance with the guidelines of Rule 10b5-1(c) under the Securities Exchange Act of 1934, and the Company's insider trading policy. According to Diamond, Cloobeck and Kraff under their trading plans intends to sell respectively, 2 million shares and 540,000 shares of Company common stock beneficially owned by them at prevailing market prices. Mr. Cloobeck said that he intends to use a portion of the net proceeds from the sales of shares to repay borrowings under the $25 million revolving loan facility entered into by Mr. Cloobeck's affiliate Cloobeck Diamond Parent. The full analyst notes on Diamond are available to download free of charge at:

http://www.analystsreview.com/Jun-26-2014/DRII/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review